New Key Statistics Module, Z-Score and F-Score
NAS:INVO Key Ratios
| Market Cap $ M | 2.73 |
| Enterprise Value $ M | 14.69 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.35 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -2.54 |
| Beneish M-Score | 1.18 |
| 10-y EBITDA Growth Rate % | -0.10 |
| 5-y EBITDA Growth Rate % | 7.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.46 |
| EV-to-EBITDA | -2.74 |
| PEG | -- |
| Shares Outstanding M | 3.91 |
| Net Margin (%) | -122.79 |
| Operating Margin % | -90.87 |
| Pre-tax Margin (%) | -122.34 |
| Quick Ratio | 0.27 |
| Current Ratio | 0.30 |
| ROA % (ttm) | -42.50 |
| ROE % (ttm) | -3,788.77 |
| ROIC % (ttm) | -26.67 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.85 |
INVO Number of Guru Trades
INVO Volume of Guru Trades
Gurus Latest Trades with NAS:INVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:INVO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
INVO Bioscience Inc Insider Transactions
No Available Data
News about NAS:INVO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers